While there have been numerous studies focusing on the consequences of EGFR activation in breast cancer [4, 5, 7], less is known regarding the specific mechanisms through which the different EGF ligands promote early breast cancer growth and progression. This evidence concerns the gene EGF and breast carcinoma.